Spero Therapeutics Inc

SPRO · Moat type: REGULIERUNG

MoatScore

6/10

Fair Value

4 USD

Margin of Safety

+62.3 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL Spero Therapeutics is a clinical-stage biotech company focused on the development and commercialization of antibiotics against multidrug-resistant gram-negative bacteria and generates revenues primarily from licensing agreements and — following the recent revenue collapse — from the wind-down of its commercial pipeline.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.